Paladin eyes Mexico and Brazil for expansion

Pharmaceutical distributor Paladin Labs (TSX:PLB) has set its sights on moving into Mexico and Brazil as it continues its strategy of expanding internationally to complement its growth in Canada. “I would like to be in more geographies, and we’re keenly interested in Mexico and Brazil and looking to do something there,” CEO Jonathan Goodman says [...]

Paladin to buy Tempra line in Canada from BMS

Paladin Labs (TSX:PLB) has entered into an agreement with Bristol Myers Squibb (NYSE:BMY) to acquire the Tempra line of products in Canada, including both syrup and drop formulations. Financial terms of the agreement were not disclosed. According to IMS Canada, the Tempra line of products achieved sales of about $3 million in 2010, representing some [...]

Tekmira and Bristol-Myers in validation program

Tekmira Pharmaceuticals (TSX:TKM) has signed a four-year agreement with Bristol-Myers Squibb (NYSE:BMY) to validate certain cellular targets using its stable nucleic acid-lipid particles (SNALP) technology in exchange for an upfront payment of $3 million (U.S.). Under the agreement, Bristol-Myers Squibb will use RNA interfering molecules formulated by Tekmira in SNALP to silence target genes of [...]